Loading asset research
+15.14%
Today
Loading 1D prices…
Company profile
Korsana Biosciences, Inc., a biotechnology company that discovers and develops novel therapies for neurodegenerative diseases. The company was incorporated in 2024 and is based in Waltham, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
WALTHAM, MA, United States
Employees
19
Fiscal year end
1231
CIK
1755237
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| AAPGAscentage Pharma Group International American Depository Shares | $1.4B | — | — | -$13.96 | -2.25% | Buy |
| RAREUltragenyx Pharmaceutical Inc. Common Stock | $1.5B | $673M | -85.44% | -$5.83 | -2.59% | Hold |
| OMEROmeros Corporation Common Stock | $1.5B | $0.00 | — | -$0.05 | -3.18% | Hold |
| PAHCPhibro Animal Health Corporation Class A Common Stock | $1.4B | $1.5B | +6.57% | $2.43 | -0.50% | Hold |
| ORICOric Pharmaceuticals Inc. Common Stock | $1.4B | $0.00 | — | -$1.47 | -0.75% | Buy |